What is HAVN Life Sciences Inc. (HAVN.CN)?

HAVN Life Sciences Inc. (HAVN.CN) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

HAVN Life Sciences Inc. (HAVN.CN)

Stock analysis · CNQ · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-0.66

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

HAVN Life Sciences Inc. (HAVN.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About HAVN Life Sciences Inc.

HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.